Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com

How Neighborhood Social Needs Drive Diabetes Care Disparities

By Hayden E. Klein

October 18th 2024

Unmet social needs in certain neighborhoods contribute to disparities in diabetes care, leading to greater reliance on emergency services, fewer preventive measures, and higher rates of complications.

Lifestyle and dietary changes have proven benefits for patients with diabetes, sometimes eliminating the need for their medications | image credit: Africa Studio - stock.adobe.com

The Off-Ramp: Novel Diabetes Reversal Program Bolsters Support of Nonpharmacological Disease Management

October 8th 2024

Diabetes | Image credit: Sherry Young – stock.adobe.com

What the Diabetes Health Economy Looks Like in 2024

By Hayden E. Klein

October 1st 2024

Senate. | Image Credit: Corgarashu - stock.adobe.com

Semaglutide Accessibility and Affordability Addressed at Senate Committee Hearing

By Cameron Santoro

September 24th 2024

Gavel and money | Image credit: BillionPhotos.com - stock.adobe.com

FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs

By Skylar Jeremias

September 20th 2024

More News

September 23rd 2016

Fitness Trackers May Not Bring Long-term Weight Loss, JAMA Study Finds

Fitbits and other trackers are everywhere, but the study by JAMA finds that they may not help users with sustained weight loss, which has long eluded researchers.

Mike Payne on Behavior Change and Modification in Diabetes Care

September 23rd 2016

Mike Payne on Behavior Change and Modification in Diabetes Care

While Omada Health’s Prevent program is designed for individuals with prediabetes, it can be adapted to patients who already have diabetes, because the program is built on behavior change and modification, explained Mike Payne, MBA, MSci, former chief healthcare development officer at Omada Health.

September 21st 2016

Cardiovascular Disease and Workplace Stress

While declining smoking rates have caused cardiovascular disease to decline overall, some risk factors are rising, such as hypertension, diabetes, and obesity.

September 21st 2016

When It Comes to Losing Weight, Genes Aren't the Whole Story

The study in BMJ found that people with the FTO gene were just as likely to lose weight through interventions, such as diet, exercise, or therapy.

September 21st 2016

Cost-Benefit of Appointment-Based Medication Synchronization in Community Pharmacies

Julie A. Patterson, BS David A. Holdford, PhD, MS, BSPharm Kunal Saxena, PhD, MS

This study conducted a cost-benefit analysis of appointment-based medication synchronization for improving adherence in patients on chronic medications for hypertension, hyperlipidemia, and diabetes.

September 21st 2016

As Metformin Combinations Proliferate, Questions Arise About Value

For some patients newly diagnosed with type 2 diabetes, skipping metformin monotherapy and going straight to fixed-dose combinations with a DPP-4 inhibitor or an SGLT2 inhibitor makes sense, evidence shows.

September 20th 2016

Representativeness of Dipeptidyl-Peptidase-4 Inhibitor Cardiovascular Outcomes Trials

Joanna P. MacEwan, PhD John J Sheehan, PhD Anne Peters, MD Jacqueline Vanderpuye-Orgle, PhD Iftekhar Kalsekar, PhD Anup Malani, PhD

Given the growing prevalence of type 2 diabetes (T2D) and its contribution to cardiovascular disease, cardiovascular outcomes trials should aim to be more representative of the average patient with T2D.

September 20th 2016

NIH Study: Depression in Early Pregnancy Linked to Gestational Diabetes

While obesity is a known risk factor in gestational diabetes, women who were obese and also were depressed when they became pregnant were at greater risk of gestational diabetes than those who did not have depression.

September 19th 2016

Sleep Disorders Linked to Heart Disease Risk in AHA Statement

Evidence has been accumulating that links irregular sleep with chronic disease, but today is the first time the American Heart Association has issued a statement on the topic.

September 19th 2016

Intarcia Poised to Seek FDA Approval for ITCA 650 After Positive A1C, CV Results

Officials say the company will file with FDA some time in the third quarter of 2016 to begin the approval process for the novel delivery system that brings a continuous, microscopic dose of exenatide to patients with type 2 diabetes.

September 16th 2016

Novo's Semaglutide Reduces CV Risk, but Shows More Retinopathy Complications

Results for Novo Nordisk’s semaglutide were reported today at the European Association for the Study of Diabetes. A filing for FDA approval is expected before the end of the year.

September 16th 2016

In US, 28% of Adults Over 50 Get No Exercise

The report showed a strong connection between states with high rates of inactivity and those with the highest rates of obesity.

September 16th 2016

5 Things to Know About Afrezza

The current issue of Evidence-Based Diabetes Management explores studies and patient access issues surrounding this closely watched inhaled insulin.

September 16th 2016

Patients Report Barriers to Getting Afrezza, but A1C Results Are Worth It

Gaining access to Afrezza can mean battling with an insurer to cover it. Sometimes the first hurdle is getting a doctor to write a prescription, according to those who've been through the process.

September 16th 2016

Afrezza: Treating Diabetes in a Physiologic Manner

R. Keith Campbell, MBA, BPharm, CDE

Professor R. Keith Campbell, MBA, BPharm, CDE, now retired from Washington State University College of Pharmacy, highlights the clinical advantages of Afrezza based on the evidence as well as his personal perspective.

September 15th 2016

Beverage Industry Sues Philadelphia to Block Soda Tax

The suit doesn't address whether soda taxes have any effect on obesity or public health, but instead hinges on finer points of Pennsylvania tax law and its constitution.

September 15th 2016

Merck, Pfizer Announce Positive Results for Ertugliflozin

Pfizer and Merck plan to file new drug applications with FDA for the SGLT2 inhibitor by the end of the year. One combination would pair ertugliflozin with Januvia, the blockbuster DPP-4 inhibitor.

September 14th 2016

Minorities, Southerners in Medicare Less Likely to Take High Blood Pressure Medication

The authors said this is the first study to examine antihypertension nonadherence down to the county level. Recommendations include greater use of combination therapy to reduce pill counts for patients with multiple chronic conditions, and synchronizing pharmacy visits to avoid multiple trips.

September 13th 2016

Military's Problem With Obesity Getting Worse, Report Finds

While the report found that the obesity rate among service members had gone up steadily since 2001, it was still only a fraction of the rate among the US population overall.

September 12th 2016

Lancet Publishes Results of Abbott's Flash Glucose Monitoring System

The trial showed use of the flash glucose monitoring system dramatically reduced the number of finger sticks while significantly reducing hypoglycemia, including at night.

September 12th 2016

What We're Reading: Clinton Has Pneumonia, Raising New Speculation About Her Health

What we're reading, September 12, 2016: Hillary Clinton's health is being called into question as her campaign confirms she has pneumonia; responders who helped during the 9/11 terrorist attacks may be sick and not know it; and Sanofi and Google team up for a diabetes venture.

Dr Scott Breidbart Explains the Concerns With Paying for Adherence

September 12th 2016

Dr Scott Breidbart Explains the Concerns With Paying for Adherence

Scott Breidbart, MD, MBA, chief clinical officer of EmblemHealth, explained that paying patients for adherence could be efficient when the payment initiatives are targeted towards members who have not shown to be adherent; however, he added that there are several limitations in paying for adherence, including the sustainability of the system and whether it will incentivize patients who are adherent to stop taking their medications.

This Week in Managed Care: September 10, 2016

September 10th 2016

This Week in Managed Care: September 10, 2016

This week, the top stories in managed care were poll results that show Hillary Clinton is more trusted than Donald Trump when it comes to healthcare, multiple studies highlighting remaining disparities in healthcare, and results of a digital diabetes self-management program.

September 10th 2016

Millennials Show Improved Health, Well-Being Compared With Older Generations

Laura Joszt, MA

Millennials are one of the few bright spots in American well-being. According to Gallup, millennials in the United States have a lower obesity rate compared with older generations, and millennials have actually seen their obesity rate go down since 2008.

September 9th 2016

Intensive Diabetes Management Adds Years to Life, Study Finds

A group of patients receiving intensive diabetes management treatment lived 7.9 years longer and had fewer cardiovascular events, the study found.

September 8th 2016

Study Finds Teens Respond to Warning Labels on Soda

The study supports earlier findings that warning labels affect parental choices of beverages for their children.

September 8th 2016

Do Cesarean Births Lead to Obesity? JAMA Pediatrics Says "Yes"

The study is the first to show a protective benefit of having a vaginal delivery after a prior cesarean birth.

September 6th 2016

Preventing Obesity and Eating Disorders in Teenagers

Pediatricians are advised to not simply focus on weight loss, but also to examine behaviors. Too rapid weight loss could be a sign of trouble and dieting in young teens often leads to being overweight later.

Ted Kyle on the Impact of the Diabetes Prevention Program

September 4th 2016

Ted Kyle on the Impact of the Diabetes Prevention Program

Ted Kyle, RPh, MBA, principal at ConscienHealth, explained that in order to prevent diabetes, a patient’s health-related risks needs to be addressed, and part of these risks stem from obesity. He added that a program like Medicare’s diabetes prevention program is exactly the tool the curb this progression.

This Week in Managed Care: September 3, 2016

September 3rd 2016

This Week in Managed Care: September 3, 2016

This week in managed care, the top stories included proposals from CMS to shore up the Affordable Care Act's marketplaces, research that highlighted the link between duration of obesity and cancer risk for women, and the results of an FDA diabetes workshop.

...

49 50 51 52 53 54 55 56 57

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions